High levels of IgG4 antibodies are not associated with an increased risk of clinical disease activity in people with…
Marisa Wexler MS
Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler MS
A specific subset of immune cells known as gamma-delta 2 T-cells plays a key role in the development of…
More than 50,000 people in the U.S. were living with IgG4-related disease (IgG4-RD) as of 2024, a new report…